Monogenic Short Stature and the Promise of Identifying Genetic Etiologies: An Expert Interview
Endocrinology Advisor spoke with Dr Andrew Dauber about the possible benefits of genetic testing for diagnosing short stature.
Growth Hormone
Grote Clinical Decision Rule May Be Best for Monitoring Growth in Children
Investigators sought to improve growth-monitoring programs by examining existing algorithms and examined the effect of using WHO vs national growth charts on algorithm performance.
Pediatric Endocrine Society Provides Guidance for Growth Hormone Use in Pediatric Patients
The guidelines focused on idiopathic short stature, growth hormone deficiency, and primary IGF-I deficiency.
FDA Approves FlexPro PenMate for Norditropin Users
The FDA has approved the FlexPro PenMate is intended for users of Norditropin, which is indicated for patients with growth hormone-related disorders, who prefer hidden needles during injection.
Ferring to Launch Pediatric Endo Products Zomacton and Zoma-Jet Soon
Ferring announced that the FDA has approved the name changes of its newly acquired products to be marketed as Zomacton (somatropin [rDNA origin]; formerly Tev-Tropin) for injection, and the needle-free delivery system as Zoma-Jet (formerly Tjet).
Growth Hormone Replacement Improves Long-Term Quality of Life in Growth Hormone Deficiency
Patients with growth hormone deficiency reaped significant benefits in quality of live over the long term.
Next post in Neuroendocrinology
